Takeda is a global biopharmaceutical company headquartered in Tokyo with over 240 years of history, evolving from a traditional medicine shop founded in Osaka in 1781 into one of the world's largest life sciences employers. The company operates across approximately 80 countries with around 50,000 employees globally, including a significant presence in the United States where it is the largest life sciences employer in Massachusetts.
The company's research and development spans six core therapeutic areas: oncology, neuroscience, gastrointestinal and inflammatory diseases, rare diseases, plasma-derived therapies, and vaccines. This portfolio reflects Takeda's focus on discovering and delivering treatments for conditions where unmet medical needs persist, combining scientific discovery with a commitment to translating research into innovative medicines.
Operations centre on patient-focused, values-based research guided by a philosophy of integrity, fairness, honesty, and perseverance. The company's stated commitment extends beyond scientific advancement to encompass an exceptional people experience and broader responsibility to patients, employees, and the planet. This orientation shapes both its approach to drug development and its engagement with stakeholders across the healthcare ecosystem.
